Nuvectis Pharma, Inc. (NVCT) — Insider Activity & Signal

Healthcare · Biotechnology · Market cap $521M · $19.63 · 52-week range $5.55–$29.27

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-06-30	Mosseri Marlio Charles	10 percent owner	50,000	$18.32	$916,000	SEC Form 4
2026-06-30	BENTSUR RON	director, 10 percent owner, officer: Chairman & CEO	12,500	$20.00	$250,000	SEC Form 4

Financial health

Altman Z-Score 19.07 · Piotroski F-Score 1/9 · Cash $32M · Debt n/a

ClearOcean signal read

ClearOcean's model currently scores NVCT as a watchlist-level signal (5/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — NVCT Form 4
How ClearOcean reads insider activity

Last updated July 07, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.